Conquering the cytokine storm in COVID‐19‐induced ARDS using placenta‐derived decidua stromal cells

Journal of Cellular and Molecular Medicine

Hoda Sadrosadat¹  Ali Pirsalehi²  Nasser Aghdami³  Mohammad Majidi⁴  Maryam Salimi⁵  Abbas Hajifathali⁵  Ghazaleh Sankanian⁵  Elham Roshandel⁵  Farshid Alaeddini⁶  Olle Ringden⁷  Behnam Sadeghi⁷  Sarvenaz Samadi Kochaksaraei⁸  Sepide Kazemi⁸ 

[1] Advanced Therapy Medicinal Product (ATMP), Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran;Department of Internal Medicine, School of Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran;Department of Infectious Diseases and Tropical Medicines, Tehran University of Medical Sciences, Tehran, Iran;Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran;Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Research Center for Health Management in Mass Gathering, Red Crescent Society of the Islamic Republic of Iran, Tehran, Iran;Translational Cell Therapy Research (TCR), Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institutet, Huddinge, Sweden;Translational Cell Therapy Research (TCR), Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institutet, Huddinge, Sweden;Advanced Therapy Medicinal Product (ATMP), Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran;

关键词: COVID‐19;    cytokine storm;    decidua stromal cells;    intensive care unit;    survival;   

DOI  :  10.1111/jcmm.16986

来源: Wiley

【 授权许可】

CC BY